Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Asia-Pacific Journal of Clinical Oncology|April 14, 2015
Radiotherapy utilization in BRAF mutation-tested metastatic melanoma in the targeted therapy eraPeter Gorayski, Marcin Dzienis, Matthew Foote, et al.Current Oncology Reports|March 7, 2023
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary ReviewSam Dowthwaite, James Jackson, Marcin Dzienis, et al.Internal Medicine Journal|November 4, 2024
Neoadjuvant chemotherapy in breast cancer: a retrospective pathway assessment in a regional cancer centreLachlan Fitzpatrick, Hui Jan Ho, Sabe Sabesan, et al.Advances in Therapy|April 24, 2025
Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment ComparisonMarcin Dzienis, Ali Mojebi, Sam Keeping, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2014
A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinomaMehlika Hazar-Rethinam, Lilia Merida de Long, Orla M Gannon, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 17, 2023
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma managementShivanshan Pathmanathan, Arsalan Tariq, Adam Pearce, et al.Molecular Cancer Therapeutics|May 29, 2015
RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell CarcinomaMehlika Hazar-Rethinam, Lilia Merida de Long, Orla M Gannon, et al.Frontiers in Oncology|July 22, 2024
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinomaRahul Ladwa, Janin Chandra, Wai-Ping Woo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV TrialMarcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, et al.European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experienceFrancis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.Pageof 3